IL6 and pulmonary fibrosis: However, the autoimmune progression in rheumatoid arthritis can lead to cachexia and severe psychiatric issues, and anti-IL-6 therapy has shown efficacy in treating affected joints, alleviating extra-articular manifestations, stabilising lung fibrosis, and reducing cachexia (77).